Understanding the Cost-Effectiveness of Covid-19 Vaccination in EthiopiaSituational Analysis of Health Technology Assessment in Ethiopia, 2022India – iDSI Case StudyGhana – iDSI Case StudyChina – iDSI Case StudyShould high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?Collaborating for cost-effective medicine use in TanzaniaImplementing diabetic foot quality standards in primary care in MumbaiThe evolution of Health Technology Assessment in ChinaProgress towards Universal Health Coverage in GhanaPRICELESS South Africa: A Regional iDSI Hub for Sub-Saharan AfricaHealth Technology Assessment on Insulin Analogue as Treatment for Type 2 Diabetes in IndonesiaUsing Health Technology Assessment to address inefficient and unequal use of Nilotinib across IndonesiaDesigning the Health Benefits Package: the essential component of a successful Universal Health Coverage programHealth Management Information Systems for Universal Health CoveragePrimary Health Care: The building block of Universal Health CoveragePromoting Healthcare Quality for effective UHC: Thailand’s Trajectory
Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
Using Health Technology Assessment to address inefficient and unequal use of Nilotinib across Indonesia
Designing the Health Benefits Package: the essential component of a successful Universal Health Coverage program